| Literature DB >> 27281821 |
Hussein H Aly1, Junya Suzuki2, Koichi Watashi3, Kazuaki Chayama4, Shin-Ichi Hoshino5, Makoto Hijikata6, Takanobu Kato2, Takaji Wakita7.
Abstract
Hepatitis B virus (HBV) is a stealth virus, minimally inducing the interferon system required for efficient induction of both innate and adaptive immune responses. However, 90% of acutely infected adults can clear the virus, suggesting the presence of other, interferon-independent pathways leading to viral clearance. Given the known ability of helicases to bind viral nucleic acids, we performed a functional screening assay to identify helicases that regulate HBV replication. We identified the superkiller viralicidic activity 2-like (SKIV2L) RNA helicase (a homolog of the Saccharomyces cerevisiae Ski2 protein) on the basis of its direct and preferential interaction with HBV X-mRNA. This interaction was essential for HBV X-mRNA degradation at the RNA exosome. The degradation of HBV X-mRNA at the RNA exosome was also mediated by HBS1L (HBS1-like translational GTPase) protein, a known component of the host RNA quality control system. We found that the redundant HBV-precore translation initiation site present at the 3'-end of HBV X-mRNA (3' precore) is translationally active. The initiation of translation from this site without a proper stop codon was identified by the non-stop-mediated RNA decay mechanism leading to its degradation. Although 3' precore is present in the five main HBV-RNA transcripts, only X-mRNA lacks the presence of an upstream start codons for large, middle, and small (L, M, and S) HBV surface proteins. These upstream codons are in-frame with 3' precore translation initiation site, blocking its translation from the other HBV-mRNA transcripts. To our knowledge, this is the first demonstration of the anti-viral function of the non-stop-mediated RNA decay mechanism.Entities:
Keywords: HBS1L; Non-Stop mediated RNA Decay (NSD); RNA Exosome; RNA degradation; RNA helicase; RNA-binding protein; SKIV2L; exosome complex; hepatitis B virus (HBV, Hep B); virus restriction factor
Mesh:
Substances:
Year: 2016 PMID: 27281821 PMCID: PMC4965548 DOI: 10.1074/jbc.M116.724641
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157